☰

Savio L.C. Woo, PhD

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Google:
"Savio Woo"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Nicole Parker grad student 2013 Mount Sinai School of Medicine
Mark A. Kay post-doc Baylor College of Medicine
Fred D. Ledley post-doc 1984- Baylor College of Medicine (Chemistry Tree)

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kubo T, Shimose S, Matsuo T, et al. (2011) Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 29: 795-800
Cormode DP, Skajaa GO, Delshad A, et al. (2011) A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjugate Chemistry. 22: 353-61
Meseck M, Huang T, Ma G, et al. (2011) A functional recombinant human 4-1BB ligand for immune costimulatory therapy of cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 175-82
Li Z, Fallon J, Mandeli J, et al. (2009) The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene. Human Gene Therapy. 20: 751-8
Altomonte J, Wu L, Meseck M, et al. (2009) Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells. Cancer Gene Therapy. 16: 266-78
Woo SL. (2008) From "Gene Therapy" to "Gene and Cell Therapy": Why? Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1899-900
Wu L, Huang TG, Meseck M, et al. (2008) rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy. Human Gene Therapy. 19: 635-47
Chen L, Woo SL. (2008) Site-specific transgene integration in the human genome catalyzed by phiBT1 phage integrase. Human Gene Therapy. 19: 143-51
Vigil A, Park MS, Martinez O, et al. (2007) Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Research. 67: 8285-92
Chen L, Thung SN, Woo SL. (2007) Metabolic basis of sexual dimorphism in PKU mice after genome-targeted PAH gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1079-85
See more...